Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR): a National Multi-center, Retrospective-prospective, Cohort Study Initiated by the Investigators

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

In this study, by establishing a clinical cohort of infective endocarditis, we observed the natural prognosis and influencing factors in the process of disease development and regression; we used multi-omics technology to understand the prognostic value of its biomarkers, and provided new ideas and evidence for the pathogenesis, clinical diagnosis and treatment of IE.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with clinically confirmed infective endocarditis

Locations
Other Locations
China
First Affiliated Hospital of Xian Jiantong University
RECRUITING
Xi'an
Contact Information
Primary
Guoliang Li
liguoliang_med@163.com
+8613759982523
Backup
Yang Yan
yangyan3@xjtu.edu.cn
+8613259882601
Time Frame
Start Date: 2024-05-09
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 2000
Treatments
Infective endocarditis group
Patients diagnosed with infective endocarditis.
Related Therapeutic Areas
Sponsors
Collaborators: Henan Provincial People's Hospital, Shaanxi Provincial People's Hospital, Xiangyang Central Hospital, 521 Hospital of NORINCO Group
Leads: First Affiliated Hospital Xi'an Jiaotong University

This content was sourced from clinicaltrials.gov